The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Biomedical Mass Spectrometry in Today's and Tomorrow's Clinical Microbiology Laboratories
Open accessAbstract
Clinical microbiology is a conservative laboratory exercise where base technologies introduced in the 19th century remained essentially unaltered. High-tech mass spectrometry (MS) has changed that. Within a few years following its adaptation to microbiological diagnostics, MS has been introduced, embraced, and broadly accepted by clinical microbiology laboratories throughout the world as an innovative tool for definitive bacterial species identification. Herein, we review the current state of the art with respect to this exciting new technology and discuss potential future applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, the clinically deployed use of wholeprotein MALDI-TOF MS for rapid identification of the species and strain of pathogenic bacteria has been adopted by thousands of hospitals and clinics worldwide 70,71 .”
From How many human proteoforms are there? (2018) · cites this paper as [70]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology
Croxatto, A., Prod'hom, G., & Greub, G. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00298.x · Cited by 997
The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry
Hoofnagle, A. N., & Wener, M. H. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.003 · Cited by 561 · cited 1×
“The use of high-performance liquid chromatography (HPLC) in tandem with MS facilitates the detection of a variety of antibody species and even antibody-antigen complexes (17).”
Cherkaoui, A., Hibbs, J., Emonet, S., Tangomo, M., Girard, M., Francois, P., & Schrenzel, J. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01881-09 · Cited by 527 · cited 1×
“Currently, the major commercial MALDI-TOF MS systems with validated microbial identification capacity are the Bruker Biotyper and the bioMérieux Vitek MS system (the latter developed by AnagnosTec [Germany] and Shimadzu Corporation [Japan]) (5, 25).”
MethodStevenson, L. G., Drake, S. K., & Murray, P. R. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01541-09 · Cited by 424
La Scola, B., & Raoult, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008041 · Cited by 383 · cited 1×
“consensus still has not been reached (11, 22).”
BackgroundFerreira, L., Sánchez-Juanes, F., González-Ávila, M., Cembrero-Fuciños, D., Herrero-Hernández, A., González-Buitrago, J. M., & Muñoz-Bellido, J. L. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02215-09 · Cited by 341 · cited 1×
“consensus still has not been reached (11, 22).”
BackgroundBurckhardt, I., & Zimmermann, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00287-11 · Cited by 335 · cited 1×
“Recently, several studies have described MS-mediated detection of degradation of beta-lactam antimicrobials (3, 16, 18).”
BackgroundHrabák, J., Walková, R., Študentová, V., Chudáčková, E., & Bergerová, T. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00984-11 · Cited by 310 · cited 2×
“It was demonstrated that this method has a sensitivity of 97% and a specificity of 98% (18).”
BackgroundDhiman, N., Hall, L., Wohlfiel, S. L., Buckwalter, S. P., & Wengenack, N. L. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02381-10 · Cited by 294 · cited 1×
“, PCR, sequencing, probe-mediated identification and detection tools, and even some selective culture-based diagnostics, MS technology offers several distinct advantages (7).”
BackgroundWolters, M., Rohde, H., Maier, T., Belmar-Campos, C., Franke, G., Scherpe, S., Aepfelbacher, M., & Christner, M. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.06.002 · Cited by 247
Cited by
How many human proteoforms are there?
Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2576 · Cited by 907
Technical aspects and inter-laboratory variability in native peptide profiling: The CE–MS experience
Mischak, H., Vlahou, A., & Ioannidis, J. P. A. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.09.025 · Cited by 213
Next-Generation Antimicrobial Susceptibility Testing
van Belkum, A., & Dunne, W. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00313-13 · Cited by 185
“Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS), a powerful tool for the rapid identification of organisms with medical importance, may also prove to be of value as an AST method (5).”
MethodRapid Clinical Bacteriology and Its Future Impact
van BelkuméG, A., Durand, R., Peyret, M., Chatellier, S., Zambardi, G., Schrenzel, J., Shortridge, D., Engelhardt, A., & Dunne, W. M. (2012) · Annals of Laboratory Medicine · doi:10.3343/alm.2013.33.1.14 · Cited by 135
“matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) [8]) and this will allow for further automation of laboratory procedures.”
MethodSelf-citationApplications of MALDI-TOF MS in environmental microbiology
Santos, I. C., Hildenbrand, Z. L., & Schug, K. A. (2016) · The Analyst · doi:10.1039/c6an00131a · Cited by 123
Metadata
- Authors
- van Belkum, A., Welker, M., Erhard, M., & Chatellier, S.
- Affiliations
- Erasmus MC (NL)
- bioMérieux (France) (FR)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2012-05
- Volume
- 50
- Issue
- 5
- Pages
- 1513-1517
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3347093
- OpenAlex
- W2055212262
- Cited by
- 100
- References
- 34
- Citations by year
- 2025: 2 · 2024: 8 · 2023: 8 · 2022: 2 · 2021: 1 · 2020: 5 · 2019: 2 · 2018: 9 · 2017: 7 · 2016: 9 · 2015: 11 · 2014: 11 · 2013: 17 · 2012: 8
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Funders
- bioMérieux
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- mass spectrometry, clinical microbiology laboratory, bacterial species identification, bacterial identification, microbiological diagnosis, future applications
- MeSH terms
- Communicable Diseases, Humans, Microbiological Techniques, Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biomedical Mass Spectrometry in Today's and Tomorrow's Clinical Microbiology Laboratories. https://app.cochat.ai/papers/10.1128/jcm.00420-12
- The paper
- van Belkum, A., Welker, M., Erhard, M., & Chatellier, S. (2012). Biomedical Mass Spectrometry in Today's and Tomorrow's Clinical Microbiology Laboratories. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00420-12
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.